SCHEMBL14470831

SCHEMBL14470831

CC(C)OC(=O)CC(C)(C)CCC(C)(C)CN1C(=O)CCC[C@@H]1CO[Si](C)(C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14453240 0.80 ALDH1A1 (0.39) —
SCHEMBL2210287 0.80 ALDH1A1 (0.41) —
SCHEMBL5819682 0.69 PTGER4 (0.36) —
SCHEMBL24795959 0.68 PDK2 (0.41) —
SCHEMBL1401084 0.68 PDK2 (0.41) —
SCHEMBL24795958 0.68 TP53 (0.38) —
SCHEMBL1401064 0.68 TP53 (0.38) —
SCHEMBL22443719 0.68 HCRTR1 (0.48) —
SCHEMBL22443722 0.68 HCRTR1 (0.48) —
SCHEMBL28523662 0.68 FKBP1A (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238710-B2 EP4 receptor agonist, compositions and methods thereof MERCK FROSST CANADA, LTD. (CA) 2007-07-03 — — US disclosed
Send feedback